Vanguard Group’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.05M Buy
1,298,089
+138,489
+12% +$752K ﹤0.01% 3083
2025
Q1
$4.02M Buy
1,159,600
+129,613
+13% +$450K ﹤0.01% 3260
2024
Q4
$10.6M Buy
1,029,987
+138,338
+16% +$1.42M ﹤0.01% 2924
2024
Q3
$12.1M Buy
891,649
+17,853
+2% +$242K ﹤0.01% 2862
2024
Q2
$11.4M Buy
873,796
+22,404
+3% +$291K ﹤0.01% 2842
2024
Q1
$8.04M Buy
851,392
+11,512
+1% +$109K ﹤0.01% 3085
2023
Q4
$9.21M Buy
839,880
+66,422
+9% +$729K ﹤0.01% 2989
2023
Q3
$4.94M Buy
773,458
+3,615
+0.5% +$23.1K ﹤0.01% 3253
2023
Q2
$3.7M Buy
769,843
+21,897
+3% +$105K ﹤0.01% 3441
2023
Q1
$3.08M Buy
747,946
+51,576
+7% +$212K ﹤0.01% 3516
2022
Q4
$2.99M Buy
696,370
+596,370
+596% +$2.56M ﹤0.01% 3518
2022
Q3
$1.9M Buy
+100,000
New +$1.9M ﹤0.01% 3764